Pfizer Values - Search News

Pfizer to Acquire Obesity Drug Start-Up Metsera

Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

Pfizer will acquire Metsera at a price of up to $86.25 a share, Metsera said in a statement.

Continue reading

Pfizer Clinches Deal for Obesity Drug Developer Metsea After a Bidding War With Novo Nordisk

· 3d · on MSN

Pfizer wins $10B bidding war for obesity drug developer Metsera in major pharmaceutical acquisition

Pfizer Wins Obesity War Against NVO, to Buy Metsera for Around $10B

The heated bidding war between Pfizer PFE and Danish rival, Novo Nordisk NVO, related to the proposed acquisition of obesity drug developer Metsera MTSR is finally over.

Continue reading

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

Pfizer wins bidding war for obesity drug startup